$TVGNW

Tevogen Inc.

CIK:0001860871|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating expenses:
Research and development	$ 3,282,557	$ 2,699,991	$ 6,417,367	$ 5,895,059
General and administrative	2,379,819	2,744,545	4,645,929	9,905,824
Total operating expenses	5,662,376	5,444,536	11,063,296	15,800,883
Loss from operations	(5,662,376)	(5,444,536)	(11,063,296)	(15,800,883)
Interest expense, net	(98,387)	(38,033)	(169,553)	(62,604)
Change in fair value of warrants	(1,177)	(21,410)	24,654	(7,553)
Net loss	(5,761,940)	(5,503,979)	(11,208,195)	(15,871,040)
Net loss attributable to common stockholders, basic	(5,839,776)	(5,641,102)	(11,560,278)	(16,145,287)
Net loss attributable to common stockholders, diluted	$ (5,839,776)	$ (5,641,102)	$ (11,560,278)	$ (16,145,287)
Net loss per share attributable to common stockholders, basic	$ (1.52)	$ (1.71)	$ (3.16)	$ (4.95)
Net loss per share attributable to common stockholders, diluted	$ (1.52)	$ (1.71)	$ (3.16)	$ (4.95)
Weighted-average common stock outstanding, basic	3,829,365	3,293,065	3,658,135	3,260,783
Weighted-average common stock outstanding, diluted	3,829,365	3,293,065	3,658,135	3,260,783

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (11,208,195)	$ (15,871,040)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	60,536	131,994
Stock-based compensation expense	6,138,216	10,532,034
Change in fair value of warrants	(24,654)	7,553
Amortization of right-of-use asset	58,659	264,192
Change in operating assets and liabilities:
Prepaid expenses and other assets	78,370	(297,763)
Other assets		9,957
Accounts payable	(510,863)	(959,943)
Accrued expenses and other liabilities	(272,583)	(71,206)
Operating lease liabilities	(58,658)	(243,544)
Net cash used in operating activities	(5,739,172)	(6,497,766)
Cash flows from investing activities:
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from loan agreement	2,000,000	3,400,000
Proceeds from pre-funded warrants, net of offering costs	2,967,000
Proceeds from issuance of shares under the sales agreement, net of offering costs	1,301,955
Capital contribution		2,500,000
Net cash provided by financing activities	6,268,955	5,900,000
Net increase (decrease) in cash	529,783	(597,766)
Cash - beginning of period	552,372	1,282,995
Cash - end of period	1,082,155	685,229
Supplementary disclosure of noncash investing and financing activities:
Issuance of shares in connection with the loan agreement	134,461
Deferred offering cost amortization	5,535
Receivables from issuance of shares under the sales agreement	18,064
Right-of-use assets obtained in exchange for operating lease liabilities		$ 1,513,607

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 1,082,155	$ 552,372
Prepaid expenses and other assets	768,286	828,592
Total current assets	2,009,260	1,539,783
Property and equipment, net	109,772	170,308
Right-of-use assets - operating leases	1,364,814	1,423,473
Deferred transaction costs	178,011	183,546
Other assets	1,065,884	1,065,884
Total assets	4,727,741	4,382,994
Current liabilities:
Accounts payable	2,829,264	3,340,127
Accrued expenses and other liabilities	1,092,580	1,499,624
Operating lease liabilities	327,740	327,740
Notes payable	1,651,000	1,651,000
Total current liabilities	6,150,584	7,068,491
Loan agreement	6,400,000	4,400,000
Operating lease liabilities	1,064,092	1,122,750
Derivative warrant liabilities	1,825	26,479
Total liabilities	13,616,501	12,617,720
Stockholders’ deficit
Common stock, $0.0001 par value; 800,000,000 shares authorized; 4,255,107 and 4,020,746 shares issued and outstanding at June 30, 2026 and December 31, 2025	426	402
Additional paid-in capital	133,179,568	122,625,431
Accumulated deficit	(150,868,744)	(139,660,549)
Total stockholders’ deficit	(8,888,760)	(8,234,726)
Total liabilities and stockholders’ deficit	4,727,741	4,382,994
Series A Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, value	2,799,990	2,799,990
Series C Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, value	6,000,000	6,000,000
Related Party [Member]
Current assets:
Due from related party	158,819	158,819
Current liabilities:
Due to related party	$ 250,000	$ 250,000